Get the Stockscreener App
0.00
100.00%
-6.81
After Hours:
7.41
7.41
+
Portage Biotech Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.
See More
Previous Close:
$6.81
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$15.86M
Revenue:
-
Net Income/Loss:
$-67.28M
P/E Ratio:
0.00
EPS:
-94.66
Net Cash Flow:
$-9.80M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$23.01
Portage Biotech Inc Stock (PRTG) Company Profile
Compare PRTG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRTG
Portage Biotech Inc
|
0.00 | 15.86M | 0 | -67.28M | -9.80M | -94.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
393.21 | 101.15B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.14 | 61.07B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.59 | 59.35B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.83 | 46.29B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.27 | 35.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Portage Biotech Inc Stock (PRTG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Mar-07-22 | Initiated | H.C. Wainwright | Buy |
| Sep-21-21 | Initiated | Oppenheimer | Outperform |
| Sep-02-21 | Initiated | B. Riley Securities | Buy |
| Aug-19-21 | Initiated | Cantor Fitzgerald | Overweight |
Portage Biotech Inc Stock (PRTG) Latest News
Published on: 2025-09-15 22:22:51 - newser.com
Is Portage Biotech Inc. building a consolidation base2025 AllTime Highs & Safe Capital Growth Tips - newser.com
Using flow based indicators on Portage Biotech Inc.Index Update & Reliable Intraday Trade Plans - newser.com
Is Portage Biotech Inc. stock bottoming out2025 Market Overview & Growth Focused Investment Plans - newser.com
Can volume confirm reversal in Portage Biotech Inc.July 2025 News Drivers & Safe Entry Trade Signal Reports - newser.com
Forecasting Portage Biotech Inc. price range with options dataJuly 2025 Analyst Calls & Technical Entry and Exit Alerts - newser.com
What indicators show strength in Portage Biotech Inc.Market Volume Report & Growth Focused Investment Plans - newser.com
Using Bollinger Bands to evaluate Portage Biotech Inc.Weekly Trade Report & Free Technical Pattern Based Buy Signals - newser.com
Published on: 2025-09-14 09:09:51 - newser.com
What does recent volatility data suggest for Portage Biotech Inc.July 2025 News Drivers & Weekly Breakout Opportunity Watchlist - newser.com
is portage biotech inc. building a consolidation baseMarket Activity Summary & Capital Efficiency Focused Strategies - newser.com
Can Portage Biotech Inc. recover in the next quarterJuly 2025 Closing Moves & Weekly Market Pulse Alerts - Newser
Heatmap analysis for Portage Biotech Inc. and competitorsEarnings Growth Summary & Verified Short-Term Plans - Newser
Applying big data sentiment scoring on Portage Biotech Inc.Analyst Upgrade & Short-Term High Return Strategies - Newser
How high can Portage Biotech Inc. stock goEarnings Risk Summary & Weekly Watchlist for Consistent Profits - Newser
Portage Biotech Inc. stock volume spike explained2025 Growth vs Value & Free Risk Controlled Daily Trade Plans - Newser
Tick level data insight on Portage Biotech Inc. volatilityMarket Growth Summary & High Accuracy Trade Signal Alerts - Newser
comparing portage biotech inc. in custom built stock radarsJuly 2025 Retail & Reliable Price Breakout Alerts - Newser
Chart based exit strategy for Portage Biotech Inc.2025 Performance Recap & Consistent Income Trade Ideas - Newser
Multi factor analysis applied to Portage Biotech Inc.July 2025 Update & Short-Term High Return Ideas - Newser
Understanding Portage Biotech Inc.’s price movementWeekly Market Report & Verified Stock Trade Ideas - Newser
Should you wait for a breakout in Portage Biotech Inc.Market Trend Review & Free Real-Time Volume Trigger Notifications - Newser
Using data filters to optimize entry into Portage Biotech Inc.2025 Trading Recap & AI Enhanced Trading Signals - Newser
How to read the order book for Portage Biotech Inc.Market Movement Recap & Free Weekly Watchlist of Top Performers - Newser
Using fundamentals and technicals on Portage Biotech Inc.July 2025 Technicals & Long-Term Safe Investment Ideas - Newser
Will Portage Biotech Inc. stock go up soonChart Signals & High Win Rate Trade Tips - Newser
Portage Biotech Inc. stock trend outlook and recovery path2025 Bull vs Bear & Risk Adjusted Buy and Sell Alerts - Newser
Portage Biotech Inc. stock trend forecastJuly 2025 Rallies & Long Hold Capital Preservation Plans - Newser
Statistical indicators supporting Portage Biotech Inc.’s strengthPortfolio Update Report & Weekly Hot Stock Watchlists - Newser
Will Portage Biotech Inc. continue its uptrendJuly 2025 Movers & High Accuracy Swing Entry Alerts - Newser
Will Portage Biotech Inc. bounce back from current supportIndex Update & Reliable Price Breakout Alerts - Newser
Chart overlay techniques for tracking Portage Biotech Inc.Entry Point & High Return Stock Watch Alerts - Newser
Institutional scanner results for Portage Biotech Inc.Market Trend Review & High Conviction Buy Zone Alerts - Newser
Does Portage Biotech Inc. qualify in momentum factor screeningWall Street Watch & Verified Momentum Stock Ideas - Newser
Applying sector rotation models to Portage Biotech Inc.2025 Price Momentum & AI Enhanced Trading Signals - Newser
Portage Biotech Inc Stock (PRTG) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.33%
0.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):